These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8339266

  • 41. Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.
    Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G, Calabretta B.
    Proc Natl Acad Sci U S A; 1994 May 10; 91(10):4504-8. PubMed ID: 8183938
    [Abstract] [Full Text] [Related]

  • 42. Reversible macrophage differentiation induced in a new human myeloid cell line by gamma interferon.
    Pintér C, Magnani I, Paini C, Clivio A.
    Cell Biol Int; 1995 Jan 10; 19(1):9-15. PubMed ID: 7613515
    [Abstract] [Full Text] [Related]

  • 43. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
    Eisbruch A, Blick M, Evinger-Hodges MJ, Beran M, Andersson B, Gutterman JU, Kurzrock R.
    Cancer; 1988 Sep 15; 62(6):1171-8. PubMed ID: 3044574
    [Abstract] [Full Text] [Related]

  • 44. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.
    Daley GQ, Van Etten RA, Baltimore D.
    Science; 1990 Feb 16; 247(4944):824-30. PubMed ID: 2406902
    [Abstract] [Full Text] [Related]

  • 45. [Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons].
    Cazzola M, Pedrazzoli P, Bergamaschi G, Buonanno C, Cuomo A, D'Uva R, Ponchio L, Rosti V, Zappone E, Ascari E.
    Haematologica; 1990 Feb 16; 75 Suppl 4():20-7. PubMed ID: 2127411
    [No Abstract] [Full Text] [Related]

  • 46. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model.
    Nagamachi A, Yamasaki N, Miyazaki K, Oda H, Miyazaki M, Honda Z, Kominami R, Inaba T, Honda H.
    Cancer Sci; 2009 Jul 16; 100(7):1219-26. PubMed ID: 19432895
    [Abstract] [Full Text] [Related]

  • 47. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.
    Tange T, Nakahara K, Mitani K, Yamasaki I, Yasuda H, Tanaka F, Mizuguchi M, Oda H, Yatomi Y, Takanashi R.
    Cancer Res; 1988 Nov 01; 48(21):6137-44. PubMed ID: 3167860
    [Abstract] [Full Text] [Related]

  • 48. A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice.
    Skórski T, Nieborowska-Skórska M, Calabretta B.
    Folia Histochem Cytobiol; 1992 Nov 01; 30(3):91-6. PubMed ID: 1286728
    [Abstract] [Full Text] [Related]

  • 49. A new Ph1-positive cell line (NCU-CML-1) from a patient with chronic myelogenous leukemia in blastic crisis.
    Nitta M, Ogisu N, Iwaki O, Wakita A, Kodama H, Takeuchi G, Kawamura H, Kohsaka K, Takada K, Mitomo Y.
    Nihon Ketsueki Gakkai Zasshi; 1988 Sep 01; 51(6):1016-25. PubMed ID: 3201895
    [No Abstract] [Full Text] [Related]

  • 50. Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
    Silla LM, Pincus SM, Locker JD, Glover J, Elder EM, Donnenberg AD, Nardi NB, Bryant J, Ball ED, Whiteside TL.
    Br J Haematol; 1996 May 01; 93(2):375-85. PubMed ID: 8639431
    [Abstract] [Full Text] [Related]

  • 51. Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line.
    Snyder DS, Wu Y, Wang JL, Rossi JJ, Swiderski P, Kaplan BE, Forman SJ.
    Blood; 1993 Jul 15; 82(2):600-5. PubMed ID: 8329715
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. An overview of some studies of chronic myelogenous leukemia: biological-clinical observations and viewing the disease as a chaotic system.
    Preisler H, Raza A.
    Leuk Lymphoma; 1993 Jul 15; 11 Suppl 1():145-50. PubMed ID: 8251888
    [Abstract] [Full Text] [Related]

  • 54. Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in mice.
    Yamamoto K, Tsuzuki S, Minami Y, Yamamoto Y, Abe A, Ohshima K, Seto M, Naoe T.
    PLoS One; 2013 Jul 15; 8(9):e74864. PubMed ID: 24098673
    [Abstract] [Full Text] [Related]

  • 55. Implantation of genetically manipulated fibroblasts into mice as antitumor alpha-interferon therapy.
    Ogura H, Tani K, Ozawa K, Nagata S, Asano S, Takaku F.
    Cancer Res; 1990 Aug 15; 50(16):5102-6. PubMed ID: 2165855
    [Abstract] [Full Text] [Related]

  • 56. Lineage non-specific down regulation of P210bcr/abl in the CML cell line, KU-812-F, during differentiation.
    Takahira H, Nishimura J, Shibata K, Hirata J, Umemura T, Nawata H.
    Leuk Res; 1990 Aug 15; 14(9):801-8. PubMed ID: 2232852
    [Abstract] [Full Text] [Related]

  • 57. [Nuclear nonhistone proteins in normal and leukemic leukocytes].
    Rybakova LP.
    Vopr Onkol; 1991 Aug 15; 37(7-8):805-12. PubMed ID: 1842633
    [Abstract] [Full Text] [Related]

  • 58. Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice.
    Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y, Hirai H.
    Blood; 1995 May 15; 85(10):2853-61. PubMed ID: 7537982
    [Abstract] [Full Text] [Related]

  • 59. Heterogeneity in protein patterns of cells from terminal blast crisis in chronic granulocytic leukemia: discrimination between lymphatic and myeloid lineages.
    Doxiadis I, Dölken P, Schneider M, Wernet P, Grosse-Wilde H.
    Leukemia; 1988 Dec 15; 2(12 Suppl):57S-62S. PubMed ID: 3199880
    [Abstract] [Full Text] [Related]

  • 60. Recombinant interferon beta in chronic myelogenous leukemia.
    Aulitzky WE, Després D, Rudolf G, Aman J, Peschel C, Huber C.
    Semin Hematol; 1993 Jul 15; 30(3 Suppl 3):14-6. PubMed ID: 7694372
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.